Article ID Journal Published Year Pages File Type
3943592 Gynecologic Oncology 2007 6 Pages PDF
Abstract
Paclitaxel 175 mg/m2, carboplatin (AUC = 5) and pegylated liposomal doxorubicin 30 mg/m2 are tolerable without supportive therapy. The usual dose intensity of paclitaxel/carboplatin was maintained by administering liposomal doxorubicin every other cycle.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Obstetrics, Gynecology and Women's Health
Preview
Paclitaxel, carboplatin and pegylated liposomal doxorubicin in ovarian and peritoneal carcinoma: A phase I study of the Gynecologic Oncology Group
Authors
, , , , ,